TY - JOUR T1 - Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.03636-2020 VL - 57 IS - 5 SP - 2003636 AU - Dominic A. Hughes AU - Idan Bokobza AU - Siobhán B. Carr Y1 - 2021/05/01 UR - http://erj.ersjournals.com/content/57/5/2003636.abstract N2 - Non-tuberculous mycobacteria (NTM) are an emerging pathogen worldwide in both cystic fibrosis (CF) and non-CF pulmonary disease (PD), with reports suggesting an increasing prevalence [1, 2]. It is an opportunistic infection acquired from the environment [3], though conflicting evidence remains around person-to-person transmission [4, 5]. Recent evidence suggests that Mycobacterium abscessus complex (MABSC) may be the most detrimental airway infection to lung function in CF [6], yet its treatment remains poorly evidenced.Non-tuberculous mycobacteria pulmonary disease affects cystic fibrosis lung health and increasingly affects children. This study reports treatment outcomes from a large CF centre, with eradication rates exceeding 60% for M. abscessus complex infection. https://bit.ly/2L8TdFMThe authors thank Alice Davenport for support with data collection and the microbiology laboratory staff, in particular Peter Darby, at the Royal Brompton Hospital, London. ER -